Author details

Full Name

Ken Suzuki

Affiliation

ORCID

Career Start Year

2016

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37034649	Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications.	medRxiv	2023
35701560	Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study.	Transl Stroke Res	2023
35918310	A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.	Nat Commun	2022
35551307	Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.	Nat Genet	2022
34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Nat Genet	2021
33589587	Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.	Nat Commun	2021
34074726	Genotype-Structure-Phenotype Correlations of Disease-Associated IGF1R Variants and Similarities to Those of INSR Variants.	Diabetes	2021
34226521	Structural basis of ethnic-specific variants of PAX4 associated with type 2 diabetes.	Hum Genome Var	2021
33836926	Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes.	J Dermatol Sci	2021
33712626	A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes.	Nat Commun	2021
33973677	Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease.	Mov Disord	2021
32866240	Increased levels of plasma nucleotides in patients with rheumatoid arthritis.	Int Immunol	2021
32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Nat Genet	2020
31957793	Genome-Wide Natural Selection Signatures Are Linked to Genetic Risk of Modern Phenotypes in the Japanese Population.	Mol Biol Evol	2020
32218440	Dimensionality reduction reveals fine-scale structure in the Japanese population with consequences for polygenic risk prediction.	Nat Commun	2020
33363050	A Metagenome-Wide Association Study of Gut Microbiome in Patients With Multiple Sclerosis Revealed Novel Disease Pathology.	Front Cell Infect Microbiol	2020
32971154	Clinical usefulness of multigene screening with phenotype-driven bioinformatics analysis for the diagnosis of patients with monogenic diabetes or severe insulin resistance.	Diabetes Res Clin Pract	2020
30718926	Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.	Nat Genet	2019
30528826	A Transethnic Mendelian Randomization Study Identifies Causality of Obesity on Risk of Psoriasis.	J Invest Dermatol	2019
30692682	Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population.	Nat Genet	2019
31382992	Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese.	J Neuroinflammation	2019
30407537	Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity.	Nucleic Acids Res	2018
28765322	Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.	Diabetes	2017
28812581	NFIA co-localizes with PPARÎ³ and transcriptionally controls the brown fat gene program.	Nature Cell Biology	2017
26818947	Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.	Nat Commun	2016